Related Experiment Video
Updated: Jan 27, 2026

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
Published on: December 26, 2015
A survey of risk tolerance to multiple sclerosis therapies
Robert J Fox1, Carol Cosenza2, Lauren Cripps2
1From the Mellen Center for Multiple Sclerosis, (R.J.F., S.N.), Department of Bioethics (P.F.), and Department of Bioethics (M.M.), Cleveland Clinic, OH; Center for Survey Research (C.C., L.C.), University of Massachusetts, Boston; Division of Biostatistics (A.S.), Washington University School of Medicine, St. Louis, MO; Dignity Health (T.T.), St. Joseph's Hospital and Medical Center, Phoenix, AZ; and Department of Biostatistics (S.S.C.), School of Public Health, University of Alabama, Birmingham. foxr@ccf.org.
Objective:
To determine tolerance to various risk scenarios associated with current multiple sclerosis (MS) therapies.
Methods:
People with MS from the North American Research Committee on Multiple Sclerosis Registry's online cohort and the National Multiple Sclerosis Society were invited to complete a questionnaire on tolerance to real-world risks associated with a hypothetical therapy. Multiple risks levels were presented, including skin rash, infection, kidney injury, thyroid injury, liver injury, and progressive multifocal leukoencephalopathy (PML).
Results:
Both PML and kidney injury had the lowest risk tolerance (RT) at 1:1,000,000, and thyroid and infection risks had the highest tolerance at 1:1,000. Men, younger individuals, and participants with greater disability reported a higher tolerance to all risk scenarios. Those who were currently taking an MS therapy reported higher tolerance than those not taking any therapy. Participants taking infusion therapies reported high tolerance to all risks, and those taking injectables reported a lower tolerance.
Conclusion:
People with MS displayed a wide range of RT for MS therapies. Our study identified sex, age, disability, and current disease-modifying therapy use to be associated with RT.
Insights
People with multiple sclerosis (MS) show varied risk tolerance for MS therapies. Factors like sex, age, disability, and current treatment influence tolerance to potential side effects, including rare but serious risks like PML.
Area of Science:
- Neurology
- Immunology
- Pharmacology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Current disease-modifying therapies (DMTs) for MS carry various risk profiles.
- Understanding patient tolerance to these risks is crucial for treatment adherence and shared decision-making.
Purpose of the Study:
- To assess the risk tolerance (RT) of individuals with MS towards different adverse events associated with hypothetical MS therapies.
- To identify demographic and clinical factors influencing RT in the MS population.
Main Methods:
- A questionnaire-based survey was administered to individuals with MS from the North American Research Committee on Multiple Sclerosis Registry and the National Multiple Sclerosis Society.
- Participants rated their tolerance to a range of potential risks, including skin rash, infection, kidney injury, thyroid injury, liver injury, and progressive multifocal leukoencephalopathy (PML).
Main Results:
- Progressive multifocal leukoencephalopathy (PML) and kidney injury exhibited the lowest risk tolerance (1:1,000,000).
- Thyroid injury and infection risks had the highest tolerance (1:1,000).
- Higher RT was reported by men, younger individuals, those with greater disability, and current MS therapy users. Infusion therapy users reported higher tolerance than injectable therapy users.
Conclusions:
- Individuals with MS demonstrate a broad spectrum of risk tolerance for MS therapies.
- Sex, age, disability level, and current DMT use are significant factors associated with risk tolerance in MS patients.
Related Concept Videos
Surveys
Introduction to Surveying, Plane Surveying and Geodetic Surveys
Types of Surveys
Survey Safety
Errors and Mistakes in Surveying
Topographic Surveying and Contours

